West Pharmaceutical Servs Q2 Adjusted EPS $2.11 Beats $1.93 Estimate, Sales $753.80M Miss $756.53M Estimate
Portfolio Pulse from Benzinga Newsdesk
West Pharmaceutical Servs (NYSE:WST) reported Q2 earnings of $2.11 per share, beating the analyst consensus estimate of $1.93 by 9.33%. However, this is a 14.57% decrease from the same period last year. The company's quarterly sales of $753.80 million missed the analyst consensus estimate of $756.53 million by 0.36%, marking a 2.27% decrease from the same period last year.
July 27, 2023 | 10:01 am
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
West Pharmaceutical Servs reported better than expected Q2 earnings but missed on sales. This mixed report could lead to uncertainty in the market.
West Pharmaceutical Servs reported Q2 earnings that beat estimates but sales that fell short. This mixed performance could lead to uncertainty among investors, potentially impacting the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100